Latest News

02.04.19

EyePoint Pharmaceuticals Announces US Commercial Launch of Yutiq

Source: EyePoint Pharmaceuticals

02.04.19

Spectralis High Magnification Module Receives CE Marking

Source: Heidelberg Engineering

01.28.19

Statement From FDA Leadership On a Record Year for Device Innovation

Source: FDA

01.22.19

FDA Issues Statement on Steps to Strengthen FDA’s 510(k) Program for Premarket Review of Medical Devices

Source: US Food & Drug Administration

01.10.19

EMA Handed Down Fewer Positive Drug Opinions in 2018

Source: Medscape

01.09.19

FDA Approved Record Number of Drugs in 2018

Source: Medscape

01.07.19

Oculogica Receives FDA Marketing Approval for EyeBOX, the First Noninvasive, Baseline-Free Test for Concussion

Source: Oculogica

01.03.19

Bausch + Lomb Announces Health Canada Approval Of Vyzulta for the Treatment of Glaucoma

Source: Bausch + Lomb

01.03.19

EyePoint Pharmaceuticals to Launch Dexycu and Yutiq in First Quarter of 2019

Source: EyePoint Pharmaceuticals

12.12.18

RayOne Aspheric Fully Preloaded IOL Receives FDA Clearance

Source: Rayner

View more stories